During the past decade, Hamilton Health Sciences conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 36 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 20 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hamilton Health Sciences" #1 sponsor was "Hamilton Health Sciences Corporation" with 35 trials, followed by "McMaster University" with 32 trials sponsored, "Population Health Research Institute" with 20 trials sponsored, "Ottawa Hospital Research Institute" with 15 trials sponsored and "Ottawa Heart Institute Research Corporation" with 15 trials sponsored. Other sponsors include 140 different institutions and companies that sponsored additional 102 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hamilton Health Sciences" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 49 trials as a collaborator, "Hamilton Health Sciences Corporation" with 24 trials as a collaborator, "McMaster University" with 19 trials as a collaborator, "Heart and Stroke Foundation of Ontario" with 8 trials as a collaborator and "Medtronic" with 7 trials as a collaborator. Other collaborators include 262 different institutions and companies that were collaborators in the rest 189 trials.

According to Clinical.Site data, the most researched conditions in "Hamilton Health Sciences" are "Atrial Fibrillation" (18 trials), "Stroke" (13 trials), "Heart Failure" (11 trials), "Myocardial Infarction" (10 trials) and "Coronary Artery Disease" (7 trials). Many other conditions were trialed in "Hamilton Health Sciences" in a lesser frequency.

Most popular intervention types in "Hamilton Health Sciences" are "Drug" (112 trials), "Other" (48 trials), "Procedure" (41 trials), "Device" (29 trials) and "Behavioral" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Rivaroxaban" (4 trials), "Vancomycin" (4 trials), "Heparin" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hamilton Health Sciences" are 241 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 68 active trials in "Hamilton Health Sciences". 2 are not yet recruiting, 41 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 139 completed trials in Hamilton Health Sciences, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Hamilton Health Sciences, 5 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 83 trials that are defined as “Not Applicable".

Hamilton Health Sciences has several departments that took part in Clinical trials: "McMaster Children's Hospital at Hamilton Health Sciences" - 263 trials, "Thrombosis Service, HHS-General Hospital" - 4 trials, "Juravinski Cancer Centre" - 384 trials, "Hamilton Health Sciences - Cardiovascular Obesity Research and Management Center" - 3 trials, "Hamilton Health Sciences - Chedoke Division" - 3 trials, "Cardiac Health & Rehabilitation Centre, Hamilton Health Sciences" - 2 trials, "Hamilton Health Sciences-General Site, Heart Investigation Unit" - 2 trials, "Hamilton General Hospital; Pharmacy" - 2 trials